Multidisciplinary Oral Rehabilitation in Osteogenesis Imperfecta: 18‐Year‐Old Case Report
ABSTRACT Osteogenesis imperfecta (OI) is a hereditary connective tissue disorder characterized by bone fragility and Type I collagen defects. Although dentinogenesis imperfecta (DI) is a classic manifestation, patients with OI may experience significant dental deterioration even in its absence due to inherent dentinal weakness.
Pegah Mosannen Mozafari +3 more
wiley +1 more source
Painful Chondral Delamination in Early-stage Osteonecrosis of the Femoral Head Precipitating Total Hip Arthroplasty. [PDF]
Agarwala S, Menon A.
europepmc +1 more source
Langerhans Cell Histiocytosis in Adults: A Canadian Multicenter Case Series
ABSTRACT Langerhans cell histiocytosis (LCH) is a rare clonal myeloid neoplasm. Canadian data on clinical characteristics, molecular profile, and treatment outcomes is limited. This study aims to report the initial experience of a Canadian rare diseases program, reflecting “real‐world” diagnostic pathways, referral patterns, and treatment heterogeneity
Stephanie Quon +7 more
wiley +1 more source
Knowledge and Self-Reported Clinical Approaches Regarding Medication-Related Osteonecrosis of the Jaw Among Final-Year Dental Students, General Dentists, and Specialist Dentists: An Exploratory Cross-Sectional Study. [PDF]
Çapar İ, Şeker Ç.
europepmc +1 more source
Applications of Mesenchymal Stromal Cells for Treatment of Diseases
This schematic summarizes the major therapeutic mechanisms of MSCs across different disease systems and highlights factors associated with MSCs dysfunction, together with current strategies to enhance MSCs function and therapeutic efficacy. This summary diagram illustrates that MSCs exert therapeutic effects in various diseases through multiple ...
Dongmei Xue, Yongsheng Li, Lei Wu
wiley +1 more source
Subchondral Insufficiency Fracture of the Knee Previously Diagnosed as Spontaneous Osteonecrosis: A Case Report With Histological Analysis. [PDF]
Za P +4 more
europepmc +1 more source
ABSTRACT N6‐methyladenosine (m6A) is the most abundant internal chemical modification of eukaryotic RNA and a central mechanism of epitranscriptomic gene regulation. Although m6A was first characterized in messenger RNA (mRNA), it is also deposited on ribosomal RNA (rRNA), circular RNA, and other RNA species, where it regulates RNA stability, decay ...
Shoichiro Kokabu, Quan Yuan
wiley +1 more source
Stem cell therapies for biological repair in osteonecrosis: advances, challenges, and clinical insights. [PDF]
Cheng D, Ou X, Long J, Zheng C, Shi S.
europepmc +1 more source
Summary The Magnolia study demonstrated that continuation of zoledronic acid (ZOL) beyond 2 years reduces the risk of progressive bone disease (PBD) in patients with multiple myeloma (MM). This follow‐up study investigated the effects of ZOL in patients achieving very good partial response (VGPR) compared to patients who did not and whether bone ...
Michael Tveden Gundesen +17 more
wiley +1 more source

